Advertisement

Long COVID Prevalent in U.S. Adults With Prior COVID-19 Infection

0

Prevalence estimated to be almost 15 percent; risk higher for older adults and women and lower with completion of primary vaccination series before infection

Omicron BA.2 Subvariant Less Severe Than Delta, Original Omicron

0

Mortality rates lower for omicron BA.2 than for delta variant and omicron B.1.1.529

Higher Work Hours Linked to Depressive Symptoms for Interns

0

Estimated change from baseline in the PHQ-9 score increased with increasing work hours

Manifestations of Hospitalization With Severe Monkeypox Described

0

47 of 57 patients had HIV infection; 95 percent were men and 68 percent were non-Hispanic Black

Disparities ID’d in Dispensing of Oral Antivirals for COVID-19

0

Substantial disparities seen in dispensing rates in high social-vulnerability zip codes versus medium-, low-vulnerability zip codes

Pooled Risk for Thrombocytopenia Increased After ChAdOx1-S Vaccine

0

Pooled 30 percent increased risk for thrombocytopenia seen after first dose of ChAdOx1-S versus BNT162b2

Overall Symptoms After BNT162b2, Other Vaccines Comparable in <5s

0

Injection-site, musculoskeletal, dermatologic, otolaryngologic symptoms more frequent; general symptoms and fever less frequent with BNT162b2 in children younger than 5 years of age

IDSA: Three-Dose Hepatitis B Vaccine Highly Protective in Persons With HIV

0

Seroprotection rate increased from 94.4 percent at eight weeks after second dose to 98.5 percent at week 24

Female Med Students Publish Less, Despite Higher Number of Research Experiences

0

Black, Hispanic students also have lower publication rates, particularly at non-top 40 schools

Excess AMI-Linked Mortality Persisted During Pandemic

0

Significant increases seen among youngest-aged men and women, even during omicron surge